S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation

Hepatology

Volumn 47, Issue 5, 2008, Pages 1655-1666

  Ara, Ainhoa Iglesias ^a   Xia, Meng ^a   Ramani, Komal ^a   Mato, José M ^b   Lu, Shelly C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; HISTONE METHYLTRANSFERASE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; METHYLTHIOADENOSINE; S ADENOSYLMETHIONINE; TUMOR NECROSIS FACTOR ALPHA; HISTONE DEMETHYLASE; LYSINE; MESSENGER RNA; RBP2 PROTEIN; S ADENOSYLHOMOCYSTEINE; SET1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; GENE EXPRESSION; LIVER INJURY; MALE; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; SINGLE DRUG DOSE; CELL STIMULATION; COMPARATIVE STUDY; GENETIC TRANSCRIPTION; HISTONE METHYLATION; HISTONE MODIFICATION; IN VIVO STUDY; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION;

ANIMALS; CHROMATIN; DNA PRIMERS; GENE EXPRESSION; HISTONES; LIPOPOLYSACCHARIDES; MALE; METHYLATION; MICE; MICE, INBRED C57BL; MONOCYTES; POLYMERASE CHAIN REACTION; RNA; S-ADENOSYLMETHIONINE; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 43949123632     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22231     Document Type: Article

References (38)

1. Mato JM, Lu SC. Role of S-adenosyl-L-methionine in liver health and injury. HEPATOLOGY 2007;45:1306-1312.
2. Su GL. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 2002;283:G256-G265.
3. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and thetapeutic target. Annu Rev Med 1994;45:491-503.
4. Li J, Billiar TR. Nitric oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am J Physiol 1999;276:G1069-G1073.
5. Veal N, Hsieh CL, Xiong S, Mato JM, Lu S, Tsukamoto H. Inhibition of lipopolysaccharide-stimulated TNF-alpha promoter activity by S-adenosylmethionine and 5′-methylthioadenosine. Am J Physiol Gastrointest Liver Physiol 2004;287:G352-G362.
6. Majano PL, García-Monzón C, García-Trevijano ER, Corrales FJ, Cámara J, Ortiz P, et al. S-adenosylmethionine modulates inducible nitric oxide synthase gene expression in rat livet and isolated hepatocytes. J Hepatol 2001;35:692-699.
7. Watson WH, Zhao Y, Chawla RK. S-adenosylmethionine attenuates the lipopolysaccharide-induced expression of the gene for tumour necrosis factor alpha. Biochem J 1999;342:21-25.
8. Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, Jongeneel CV. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med 1990;171:35-47.
9. Collart MA, Baeuerle P, Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol 1990;10:1498-1506.
10. Drouet C, Shakhov AN, Jongeneel CV. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-alpha promoter in primary macrophages. J Immunol 1991;147:1694-1700.
11. Kim YM, Lee BS, Yi KY, Paik SG. Upstream NF-kappaB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in intetferon-gamma plus lipopolysaccharide-induced RAW 264.7 macrophages. Biochem Biophys Res Commun 1997;236:655-660.
12. Jenuwein T, Allis CD. Translating the histone code. Science 2001;293:1074-1080.
13. Kutdistani SK, Tavazoie S, Grunstein M. Mapping global histone acetylation patterns to gene expression. Cell 2004;117:721-733.
14. Ashburner BP, Westerheide SD, Baldwin AS Jr. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 2001;21:7065-7077.
15. Ou X, Yang H, Ramani K, Ara AI, Chen H, Mato JM, et al. Inhibition of human betaine-homocysteine methyltransferase expression by S-adenosylmethionine and methylthioadenosine. Biochem J 2007;401:87-96.
16. Santos-Rosa H, Schneider R, Bannistet AJ, Sherriff J, Bernstein BE, Emre NC, et al. Active genes are tri-methylated at K4 of histone H3. Nature 2002;419:407-411.
17. Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 2001;410:116-120.
18. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 2007;130:77-88.
19. Wang H, Cao R, Xia L, Erdjument-Bromage H, Borchers C, Tempst P, et al. Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol Cell 2001;8:1207-1217.
20. Guenthet MG, Jenner RG, Chevalier B, Nakamura T, Croce CM, Canaani E, et al. Global and Hox-specific roles for the MLL1 methyltransferase. Proc Natl Acad Sci U S A 2005;102:8603-8608.
21. Klose RJ, Yan Q, Tothova Z, Yamane K, Erdjument-Bromage H, Tempst P, et al. The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 2007;128:889-900.
22. Iwase S, Lan F, Bayliss P, de la Torre-Ubieta L, Huarte M, Qi HH, et al. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 2007;128:1077-1088.
23. Song MR, Ghosh A. FGF2-induced chromatin remodeling regulates CNTF-mediated gene expression and astrocyte differentiation. Nat Neurosci 2004;7:229-235.
24. Chau CM, Lieberman PM. Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J Virol 2004;78:12308-12319.
25. Fish JE, Matouk CC, Rachlis A, Lin S, Tai SC, D'Abreo C, et al. The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. J Biol Chem 2005;280:24824-24838.
26. Musri MM, Corominola H, Casamitjana R, Gomis R, Parrizas M. Histone H3 lysine 4 dimethylation signals the transcriptional competence of the adiponectin promoter in preadipocytes. J Biol Chem 2006;281:17180-17188.
27. Clarke SG. Inhibition of mammalian protein methyltransferases by 5′-methylthioadenosine (MTA): a mechanism of action of dietary SAMe? Enzymes 2006;24:467-493.
28. Chen H, Xia M, Lin M, Yang H, Kuhlenkamp J, Li T, et al. Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells. Gastroenterology 2007;133:207-218.
29. Bhoumik A, Huang TG, Ivanov V, Gangi L, Qiao RF, Woo SL, et al. An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis. J Clin Invest 2002;110:643-650.
30. Dignam JD, Lebovitz RM, Roeder R. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983;11:1475-1489.
31. Barthel R, Tsytsykova AV, Barczak AK, Tsai EY, Dascher CC, Brenner MB, et al. Regulation of tumot necrosis factor alpha gene expression by mycobacteria involves the assembly of a unique enhanceosome dependent on the coactivator proteins CBP/p300. Mol Cell Biol 2003;23:526-533.
32. Ferro AJ, Vandenbark AA, MacDonald MR. Inactivation of S-adenosylhomocysteine hydrolase by 5′-deoxy-5′-methylthioadenosine. Biochem Biophys Res Commun 1981;100:523-531.
33. Clarke S, Banfield K. S-adenosylmethionine-dependent methyltransferases: potential targets in homocysteine-linked pathology. In: Carmel R, Jacobsen D, eds. Homocysteine in Health and Disease. Cambridge, England: Cambridge University Press; 2001:63-78.
34. Hevia H, Varela-Rey M, Corrales FJ, Berasain C, Martínez-Chantar ML, Latasa MU, et al. 5′-Methylthioadenosine modulates the inflammatory response to endotoxin in mice and in rat hepatocytes. HEPATOLOGY 2004;39:1088-1098.
35. Mato JM, Camara J, Fernandez de Paz J, Caballeria L, Coll S, Caballero A, et al. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol 1999;30:1081-1089.
36. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase Cell 1995;81:641-650. [published correction appears in Cell 1995;81:1170].
37. Narayanan A, Ruyechan WT, Kristie TM. The coactivator host cell factor-1 mediates Set1 and MLL1 H3K4 trimethylation at herpesvirus immediate early promoters for initiation of infection. Proc Natl Acad Sci U S A 2007;104:10835-10840.
38. Jeong SY, Lee JH, Kim HS, Hong SH, Cheong CH, Kim IK. 3-Deazaadenosine analogues inhibit the production of tumour necrosis factor-alpha in RAW264.7 cells stimulated with lipopolysaccharide. Immunology 1996;89:558-562.